查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434562

适体市场：按产品、应用和最终用户划分 - 2024-2030 年全球预测

Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年适配体市场规模为13.4亿美元，预计2024年将达到14.8亿美元，2030年将达到27.7亿美元，复合年增长率为10.91%。

全球适体市场

主要市场统计
基准年[2023] 13.4亿美元
预测年份 [2024] 14.8亿美元
预测年份 [2030] 27.7亿美元
复合年增长率（%） 10.91%
适体市场-IMG1

适体是含有 DNA、RNA 或修饰核酸的单链寡核苷酸，能够与目标分子特异性结合并具有高亲和性。这些目标分子可以是蛋白质、胜肽、小有机化合物、核酸或整个细胞。适体的重要性在于其独特的性质在生物技术中的广泛应用。适配体对抗体等标靶具有较高的特异性和亲和性，具有体积小、易于化学合成、可修饰稳定性等优点，可用于靶向药物递送系统，是一种很好的诊断工具。此外，适体由天然存在的核苷酸组成，因此与抗体相比具有最小的免疫抗原性。适体可以设计用于多重检测或与其他生物功能部分（例如奈米颗粒或萤光染料）结合，增加其在各个领域的适用性。由于多种因素，适体市场正在经历显着增长，包括药物开发投资、政府促进个人化医疗的倡议以及基于适体的生物感测器和照护现场诊断的不断发展。然而，开发复杂性和监管限制等挑战给适体市场带来了障碍。市场相关人员正在研究新的製造技术，以简化适配体的製造流程并提高其品质。合成化学和高通量筛检技术的进步使得修饰核酸文库的开发能够产生更稳定且功能性更强的适体。

区域洞察

美洲地区代表了全球适体市场的重大发展，拥有完善的生物技术领域，并透过强大的学术基础和对研发活动的大量投资而加强。在美洲地区的应用领域，适配体广泛应用于针对癌症治疗、发炎疾病治疗、诊断和管理的药物发现活动。适体在环境监测和食品安全应用方面取得了重大进展。在德国、法国和英国等先进的生物製药领域，适配体广泛用于治疗应用和诊断工具的开发。欧洲研究人员在利用适配体检测植物病原体和监测食品污染的农业应用方面取得了重大进展。在亚洲，由于生物製药投资和政府资助的增加，适配体正处于早期阶段，具有快速成长的潜力。中国、印度、韩国和日本等新兴市场正在主导该地区的研究工作。儘管与美洲和欧洲相比，亚洲的专业适配体公司数量有限，但这些国家有几家大型製药公司将适配体研究作为其药物发现管道的一部分来进行。亚洲研究人员对使用适配体作为诊断工具和治疗方法来治疗心血管和神经退化性疾病等慢性疾病越来越感兴趣。

FPNV定位矩阵

FPNV定位矩阵对于评估适配体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对适配体市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-适配体市场规模和预测是多少？

2-适配体市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-适配体市场的技术趋势和法律规范是什么？

4-适配体市场主要厂商的市场占有率为何？

5-进入适配体市场的合适型态或策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 投资药物开发并使用适体进行药物结合亲和性
      • 政府鼓励个人化医疗和治疗的倡议
      • 基于适体的生物感测器和照护现场诊断的不断发展
    • 抑制因素
      • 对适体半衰期短的担忧
    • 机会
      • 适体生产与功能的技术进步
      • 适体在食品安全与真伪检测的应用的出现
    • 任务
      • 开发复杂性和监管限制
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章适体市场：副产品

  • 核苷酸碱基
    • DNA
    • RNA
    • XNA
  • 基于胜肽的

第七章适体市场：依应用分类

  • 诊断
  • 研究与开发
  • 治疗药物的开发

第 8 章适体市场：依最终使用者划分

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约研究组织

第九章 美洲适体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区适配体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲适配体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强
    • 奖项/奖励/扩展

第13章竞争产品组合

  • 主要公司简介
    • 2bind GmbH
    • Agilent Technologies, Inc.
    • Aptagen, LLC
    • Aptamer Group
    • Aptamer Sciences, Inc.
    • AptaTargets SL
    • Aptus Biotech SL
    • ATDBio Ltd.
    • Base Pair Biotechnologies, Inc.
    • Basking Biosciences
    • Cage Bio, Inc.
    • Creative Biogene
    • Drive Therapeutics, LLC
    • IVERIC bio, Inc.
    • Kaneka Corporation
    • Maravai LifeSciences
    • Mediomics, LLC
    • NeoVentures Biotechnology, Inc.
    • NOVAPTECH
    • Novartis AG
    • Qualigen, Inc.
    • Raptamer Discovery Group
    • SomaLogic, Inc.
    • TAGCyx Biotechnologies Inc.
    • Vivonics, Inc.
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-4358BACA83A7

[183 Pages Report] The Aptamers Market size was estimated at USD 1.34 billion in 2023 and expected to reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030.

Global Aptamers Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.34 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.77 billion
CAGR (%) 10.91%
Aptamers Market - IMG1

Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically and with high affinity to their target molecules. These target molecules can be proteins, peptides, small organic compounds, nucleic acids, or whole cells. The importance of aptamers lies in their numerous applications in biotechnology due to their unique characteristics. They exhibit high specificity and affinity for their targets akin to antibodies and possess advantages such as smaller size, ease of chemical synthesis, and modification for stability, making them suitable candidates for targeted drug delivery systems or diagnostic tools. Moreover, aptamers have minimal immunogenicity compared to antibodies since they comprise natural nucleotides. Aptamers can be engineered for multiplex detection or combined with other biofunctional moieties, such as nanoparticles or fluorophores, to enhance their applicability across various sectors. The aptamers market is experiencing significant growth driven by various factors, such as investments in drug development, government initiatives promoting personalized medicine, and the rising development of aptamer-based biosensors and point-of-care diagnostics. However, challenges such as development complexity and regulatory limitations pose hurdles for the aptamers market. Market players are working on new production technologies to ease the aptamer manufacturing process and improve their quality. Advances in synthetic chemistry and high-throughput screening technologies have enabled the development of modified nucleic acid libraries to generate more stable and functional aptamers.

Regional Insights

The Americas region exhibits significant advancements in the global aptamer market, with an established biotechnology sector bolstered by a strong academic foundation and substantial investment in R&D activities. In terms of application areas within the Americas region, aptamers are widely used in drug discovery efforts targeting cancer therapy, treatment of inflammatory diseases, diagnosis & management. Significant advancements have been made in employing aptamers for environmental monitoring and food safety applications. Europe represents an evolving landscape for aptamers as countries such as Germany, France, and the UK have advanced biopharmaceutical sectors that use this technology extensively for therapeutic applications or diagnostics tool development. European researchers have made significant strides in using aptamers for agricultural applications, wherein they are employed to detect plant pathogens or monitor food contamination. In Asia, the aptamer landscape is at a nascent stage with potential for rapid growth due to increasing biopharmaceutical investments and government funding initiatives. Emerging markets, including China, India, South Korea, and Japan, are leading regional research activities. Although there is a limited number of dedicated aptamer-based companies in Asia compared to the Americas and Europe, these countries harbor several large-scale pharmaceutical entities that engage in aptamer research as part of their drug discovery pipelines. Asian researchers have demonstrated a growing interest in utilizing aptamers as diagnostic tools or therapeutic agents for chronic disease management, such as cardiovascular ailments or neurodegenerative conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aptamers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aptamers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Nucleotide Based
      • DNA
      • RNA
      • XNA
    • Peptide Based
  • Application
    • Diagnostics
    • Research & Development
    • Therapeutics Development
  • End-User
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aptamers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aptamers Market?

3. What are the technology trends and regulatory frameworks in the Aptamers Market?

4. What is the market share of the leading vendors in the Aptamers Market?

5. Which modes and strategic moves are suitable for entering the Aptamers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Aptamers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Investments in drug development and use of aptamers for drug-binding affinity
      • 5.1.1.2. Government initiatives encouraging personalized medicine and treatment
      • 5.1.1.3. Rising development of aptamer-based biosensors and point-of-care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with short half-life of aptamers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in aptamer production and functionalities
      • 5.1.3.2. Emergence use of aptamers for food safety and authenticity testing
    • 5.1.4. Challenges
      • 5.1.4.1. Development complexity and regulatory limitations
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Aptamers Market, by Product

  • 6.1. Introduction
  • 6.2. Nucleotide Based
    • 6.3.1. DNA
    • 6.3.2. RNA
    • 6.3.3. XNA
  • 6.3. Peptide Based

7. Aptamers Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Research & Development
  • 7.4. Therapeutics Development

8. Aptamers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Aptamers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aptamers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aptamers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
      • 12.3.1.2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer's Disease Diagnostic Test
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 2bind GmbH
    • 13.1.2. Agilent Technologies, Inc.
    • 13.1.3. Aptagen, LLC
    • 13.1.4. Aptamer Group
    • 13.1.5. Aptamer Sciences, Inc.
    • 13.1.6. AptaTargets SL
    • 13.1.7. Aptus Biotech S.L.
    • 13.1.8. ATDBio Ltd.
    • 13.1.9. Base Pair Biotechnologies, Inc.
    • 13.1.10. Basking Biosciences
    • 13.1.11. Cage Bio, Inc.
    • 13.1.12. Creative Biogene
    • 13.1.13. Drive Therapeutics, LLC
    • 13.1.14. IVERIC bio, Inc.
    • 13.1.15. Kaneka Corporation
    • 13.1.16. Maravai LifeSciences
    • 13.1.17. Mediomics, LLC
    • 13.1.18. NeoVentures Biotechnology, Inc.
    • 13.1.19. NOVAPTECH
    • 13.1.20. Novartis AG
    • 13.1.21. Qualigen, Inc.
    • 13.1.22. Raptamer Discovery Group
    • 13.1.23. SomaLogic, Inc.
    • 13.1.24. TAGCyx Biotechnologies Inc.
    • 13.1.25. Vivonics, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
  • FIGURE 2. APTAMERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. APTAMERS MARKET DYNAMICS
  • FIGURE 7. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 8. APTAMERS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. APTAMERS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. APTAMERS MARKET SIZE, BY XNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. APTAMERS MARKET SIZE, BY PEPTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. APTAMERS MARKET LICENSE & PRICING